Innoviva (INVA) Profit After Tax (2010 - 2026)
Innoviva (INVA) reported Profit After Tax of $186.6 million for Q1 2026, up 500.56% on a YoY basis from $31.1 million in Q1 2025, and up 250.12% quarter-over-quarter from -$124.3 million in Q4 2025.
Innoviva (INVA) Profit After Tax (2010 - 2026) Analysis & Trends
Innoviva has reported Profit After Tax for 17 years, with the latest figure at $186.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 500.56% year-over-year to $186.6 million; the trailing twelve-month figure through Mar 2026 stood at $215.9 million (up 378.73% YoY), and the FY2025 full-year result was $271.2 million, up 1059.22% from the prior year.
- Profit After Tax for Q1 2026 stood at $186.6 million, up from -$124.3 million in the prior quarter.
- The five-year high for Profit After Tax was $229.3 million in Q3 2022, with the low at -$124.3 million in Q4 2025.
- Historically, Profit After Tax has averaged $32.4 million across 5 years, with a median of $21.4 million in 2022.
- The largest YoY upside for Profit After Tax was 7312.04% in 2025 against a maximum downside of 4880.69% in 2025.
- Innoviva's Profit After Tax stood at -$10.3 million in 2022, then tumbled by 92.43% to -$19.8 million in 2023, then jumped by 113.1% to $2.6 million in 2024, then plunged by 4880.69% to -$124.3 million in 2025, then surged by 250.12% to $186.6 million in 2026.
- The last three Profit After Tax figures came in at $186.6 million (Q1 2026), -$124.3 million (Q4 2025), and $89.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Innoviva | 1.65 Bn | 1.05 Bn | 75.83 Mn | 186.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186.60 Mn |
| Dec 31, 2025 | -124.30 Mn |
| Sep 30, 2025 | 89.91 Mn |
| Jun 30, 2025 | 63.69 Mn |
| Mar 31, 2025 | -46.58 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | -34.69 Mn |
| Mar 31, 2024 | 36.53 Mn |
| Dec 31, 2023 | -19.85 Mn |
| Sep 30, 2023 | 82.05 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 34.87 Mn |
| Dec 31, 2022 | -10.31 Mn |
| Sep 30, 2022 | 229.35 Mn |
| Jun 30, 2022 | 21.37 Mn |
| Mar 31, 2022 | 37.86 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | 102.65 Mn |
| Jun 30, 2021 | 110.85 Mn |